Trial Profile
A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Therapeutic Use
- 27 May 2014 New trial record